Ranolazine

Common brands: Aspruzyo Sprinkle, Aspirin 325, Aspirin 81, Ecotrin, Bayer Low Dose

Top reporter: A2a Integrated Pharmaceuticals

Anti-anginal [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Nitrate Vasodilator [EPC]Platelet Aggregation Inhibitor [EPC]Loop Diuretic [EPC]
10,189
Total Reports
3,278
Serious Reports
1,321
Death Reports
30
Reported Reactions
Death Report Ratio: High (12.96%)

Patient Demographics

Male
5,807
Female
3,949

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Ranolazine.

# Reaction Reports % of Total
1 DEATH 822
8.7%
2 MYOCARDIAL INFARCTION 644
6.8%
3 CHEST PAIN 612
6.5%
4 ANGINA PECTORIS 595
6.3%
5 STENT PLACEMENT 582
6.2%
6 DYSPNOEA 432
4.6%
7 DIZZINESS 416
4.4%
8 FALL 373
4.0%
9 CEREBROVASCULAR ACCIDENT 356
3.8%
10 CARDIAC DISORDER 306
3.2%
11 OFF LABEL USE 285
3.0%
12 MALAISE 284
3.0%
13 NAUSEA 265
2.8%
14 DIABETES MELLITUS 259
2.7%
15 FATIGUE 255
2.7%
16 DRUG INTERACTION 250
2.6%
17 INTENTIONAL PRODUCT USE ISSUE 239
2.5%
18 CARDIAC FAILURE CONGESTIVE 221
2.3%
19 PNEUMONIA 219
2.3%
20 HYPOTENSION 207
2.2%
21 DRUG INEFFECTIVE 206
2.2%
22 CARDIAC OPERATION 195
2.1%
23 HYPOACUSIS 194
2.1%
24 PRODUCT USE ISSUE 193
2.0%
25 ASTHENIA 191
2.0%
26 DIARRHOEA 179
1.9%
27 HEADACHE 175
1.9%
28 VOMITING 174
1.8%
29 HYPERTENSION 161
1.7%
30 ATRIAL FIBRILLATION 148
1.6%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.